DocGo (DCGO) Competitors $2.64 -0.09 (-3.30%) Closing price 04:00 PM EasternExtended Trading$2.66 +0.01 (+0.57%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. GRAL, AVAH, CDNA, FTRE, PNTG, CSTL, FLGT, AUNA, TALK, and EHABShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Grail (GRAL), Aveanna Healthcare (AVAH), CareDx (CDNA), Fortrea (FTRE), The Pennant Group (PNTG), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Auna (AUNA), Talkspace (TALK), and Enhabit (EHAB). These companies are all part of the "healthcare" industry. DocGo vs. Grail Aveanna Healthcare CareDx Fortrea The Pennant Group Castle Biosciences Fulgent Genetics Auna Talkspace Enhabit Grail (NASDAQ:GRAL) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings. Do insiders & institutionals have more ownership in GRAL or DCGO? 56.4% of DocGo shares are owned by institutional investors. 2.7% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer GRAL or DCGO? In the previous week, DocGo had 1 more articles in the media than Grail. MarketBeat recorded 6 mentions for DocGo and 5 mentions for Grail. Grail's average media sentiment score of 1.19 beat DocGo's score of 0.85 indicating that Grail is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Grail 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GRAL or DCGO more profitable? DocGo has a net margin of 4.35% compared to Grail's net margin of 0.00%. DocGo's return on equity of 8.90% beat Grail's return on equity.Company Net Margins Return on Equity Return on Assets GrailN/A N/A N/A DocGo 4.35%8.90%5.72% Which has stronger valuation & earnings, GRAL or DCGO? DocGo has higher revenue and earnings than Grail. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGrail$125.60M7.56N/AN/AN/ADocGo$616.56M0.44$6.86M$0.1715.62 Do analysts prefer GRAL or DCGO? Grail currently has a consensus target price of $20.00, suggesting a potential downside of 28.57%. DocGo has a consensus target price of $4.89, suggesting a potential upside of 84.24%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Grail 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00DocGo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Does the MarketBeat Community prefer GRAL or DCGO? DocGo received 47 more outperform votes than Grail when rated by MarketBeat users. Likewise, 74.60% of users gave DocGo an outperform vote while only 0.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformGrailOutperform VotesNo VotesUnderperform Votes4100.00% DocGoOutperform Votes4774.60% Underperform Votes1625.40% SummaryDocGo beats Grail on 12 of the 14 factors compared between the two stocks. Remove Ads Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$269.75M$861.41M$5.64B$7.83BDividend YieldN/A2.41%4.57%4.01%P/E Ratio9.4545.2823.1318.64Price / Sales0.443.52388.4791.24Price / Cash23.6226.1438.1634.64Price / Book0.902.686.884.23Net Income$6.86M-$5.50M$3.20B$247.06M7 Day Performance-0.94%-0.56%-2.80%-2.15%1 Month Performance-14.40%-7.28%1.74%-5.71%1 Year Performance-34.53%64.02%9.80%-0.84% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo3.0644 of 5 stars$2.64-3.3%$4.89+85.3%-32.8%$269.24M$616.56M9.432,920Short Interest ↓GRALGrail0.7428 of 5 stars$32.13+6.1%$20.00-37.8%N/A$1.09B$125.60M0.001,360Positive NewsGap UpAVAHAveanna Healthcare0.5996 of 5 stars$5.58+5.5%$4.94-11.5%+125.3%$1.09B$2.02B-16.4133,500CDNACareDx3.3291 of 5 stars$19.61+1.5%$31.83+62.3%+74.4%$1.09B$333.79M-7.26740Positive NewsFTREFortrea2.5074 of 5 stars$9.40+7.2%$19.00+102.1%-79.1%$847.88M$2.70B-2.7518,000High Trading VolumePNTGThe Pennant Group3.6968 of 5 stars$24.29+3.8%$34.80+43.3%+28.1%$836.31M$695.24M35.725,340CSTLCastle Biosciences2.3052 of 5 stars$20.98+2.2%$40.00+90.7%-5.5%$587.59M$332.07M104.91540Analyst ForecastFLGTFulgent Genetics2.9146 of 5 stars$16.96-0.8%$16.00-5.7%-22.3%$522.86M$283.47M-3.071,010Short Interest ↑Positive NewsHigh Trading VolumeAUNAAuna3.8304 of 5 stars$7.06+0.4%$13.53+91.6%-31.4%$521.86M$4.39B18.5814,958TALKTalkspace4.2389 of 5 stars$2.87+2.5%$4.38+52.4%-25.2%$483.41M$187.59M287.29500Short Interest ↓Positive NewsEHABEnhabit1.522 of 5 stars$8.95-1.1%$8.50-5.0%-22.9%$451.70M$1.03B-3.8610,800Positive News Remove Ads Related Companies and Tools Related Companies GRAL Alternatives AVAH Alternatives CDNA Alternatives FTRE Alternatives PNTG Alternatives CSTL Alternatives FLGT Alternatives AUNA Alternatives TALK Alternatives EHAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DCGO Stock Free DCGO Stock Alerts